Abstract:
After several years of scientific and biomedical laboratory experiments, Ensil succeeds in developing a nanotechnology-based sensor to detect gp 21 and gp 27 HIV virus through urine.
"After several years of scientific and biomedical laboratory experiments to develop nanotechnology-based sensors and detectors, we are extremely proud to make this announcement," said Farsad Kiani, Presiden and CEO of Ensil Group of Companies.
Mr. Kiani continued, "When the Ensil Canada Ltd. HIV diagnostic device is commercialized and put on the market, high-risk groups may get tested at more convenient locations as a do-it-yourself, real-time, cost-effective way to test and receive their own test results in strictest confidence."
Ensil Canada Ltd. Chief Scientist and the Lead Project CSO added after the successful experiments with the antibody to HIV gp41, Ensil will try to validate the same results with its proprietary detection technology to detect gp120 so a wide range of HIV strain could be detected.
####
About Ensil Canada Ltd.
Ensil Canada Ltd., a member of Ensil group of companies (www.ensil.com) focuses on enhancing mission critical technologies in the areas of aerospace, defence, telecommunication and medical diagnostic equipment. Ensil's R&D divisions' mission is to develop new technologies or improve existing technologies through in-house research activities. After nearly 30 years of scientific and technological experience, Ensil has required resources to modify, re-design, reverse engineer or repair circuit boards and assemblies used in medical, industrial and military equipment.
For more information, please click here
Contacts:
Copyright ? 24-7 Press Release
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
Researchers unravel Dephotex technology January 3rd, 2012
DNA motors on January 3rd, 2012
MRI: Quantum computing meets medicine January 3rd, 2012
Graphene-based Catalyst Shows Promise for Fuel Cells January 3rd, 2012
Nanomedicine
Where nanotechnology and medicine meet: University of Alberta researcher shrinks medical tests, makes them more affordable January 3rd, 2012
NOVAVAX Reports Progress Under Joint Venture in India With Cadila Pharmaceuticals January 3rd, 2012
DNA motors on January 3rd, 2012
Research and Innovation Driving Global RNAi Market Finds RNCOS December 27th, 2011
Sensors
New technique makes it easier to etch semiconductors December 22nd, 2011
Demonstrating the versatility of electrochemical sensors December 18th, 2011
Battelle-R&D Magazine Annual Global Funding Forecast Predicts R&D Spending Growth Will Continue While Globalization Accelerates: 2012 Funding Forecast Shows Promising Global Growth but High Expectations for Commercial Payoff December 17th, 2011
CEA-Leti and Caltech Alliance for Nanosystems VLSI Announce First Startup: Analytical Pixels Launched to Design, Manufacture, and Commercialize Analysis Systems Based on New Concept of Miniaturized Chromatography December 14th, 2011
Announcements
Researchers unravel Dephotex technology January 3rd, 2012
DNA motors on January 3rd, 2012
MRI: Quantum computing meets medicine January 3rd, 2012
Graphene-based Catalyst Shows Promise for Fuel Cells January 3rd, 2012
Source: http://c.moreover.com/click/here.pl?r5696282324
3 10 to yuma west virginia football west virginia football black friday violence black friday violence il postino il postino
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.